SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (188)3/23/2006 8:26:20 AM
From: kenhott  Read Replies (1) | Respond to of 332
 
Don't have much smart to say that you would not know already. If 1067 hits, it will be good enough to supercharge the stock. Competition should be branded vs. branded, unlikely anyone will run large trials with generic solution. One should expect decent dropouts in these trials due to IVUS, etc.